Skip to content
AnalystLens

Keurig Dr Pepper 8-K Report, Executive Changes (Feb 28, 2025)

Reports
Leadership Changes·Other Events·Exhibits & Filings
Filing Date
Filed February 28, 2025
Period End
February 28, 2025
Security
KDP
In the record · 2016–202610-K1210-Q338-K216

KDP filed 12 annual reports (10-K), 33 quarterly reports (10-Q) and 216 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Jan ’18Jan ’18
  2. Material agreement8-K · Apr ’20Apr ’20
  3. Leadership change8-K · Nov ’22Nov ’22
  4. Leadership change8-K · Aug ’26Aug ’26

Summary

Summary of the 8-K filed February 28, 2025. Cited figures are marked; the original filing is the authoritative source.

On February 28, 2025, JAB BevCo B.V.

(the Selling Stockholder) completed a registered public secondary offering of 73,000,000 shares of Keurig Dr Pepper Inc. (KDP) common stock. The underwriter, J.P. Morgan Securities LLC, exercised in full its 30-day option to buy an additional 10,950,000 shares, bringing the total to 83,950,000 shares.

The Selling Stockholder received gross proceeds of approximately $2.7 billiona. The Company did not receive any proceeds from the sale. Separately, three directors affiliated with JAB BevCo B.V.

(Joachim Creus, Frank Engelen and Olivier Goudet) notified the Executive Chairman on February 26, 2025 that each intends to resign from the Board effective upon closing of the offering. The filing states that none of the resignations resulted from any disagreement with the Company or the Board.

As a result, the Board will be reduced from eleven to eight directors. The offering was made under a previously filed Form S-3 registration statement (File No. 333-266989) and a resale prospectus supplement, and the Underwriting Agreement dated February 26, 2025 is filed as Exhibit 1.1.

Key Highlights

  1. JAB BevCo B.V. completed a secondary offering of 73,000,000 shares of KDP common stock on February 28, 2025.
  2. The underwriter exercised its 30-day option in full on February 27, 2025, for 10,950,000 additional shares, for a total of 83,950,000 shares sold.
  3. The Selling Stockholder received gross proceeds of approximately $2.7 billion; the Company received no proceeds from the sale.
  4. Three JAB-affiliated directors (Joachim Creus, Frank Engelen and Olivier Goudet) intend to resign effective upon closing of the offering.
  5. The Board's size will decrease from eleven to eight directors, and the filing states the resignations were not the result of any disagreement with the Company or the Board.
  6. JAB BevCo B.V. is a holding company majority-owned by JAB Holding Company s.à.r.l.
  7. The offering was registered under Form S-3 (File No. 333-266989) and a resale prospectus supplement, with the Underwriting Agreement filed as Exhibit 1.1.

Frequently Asked Questions

  1. How many KDP shares were sold in the secondary offering, and who sold them?

    JAB BevCo B.V., the Selling Stockholder, sold 83,950,000 shares of common stock. This includes the 73,000,000 shares in the base offering and 10,950,000 shares from the underwriter's option, which was exercised in full.

  2. Did KDP receive any money from the offering?

    No. The filing states that the Company did not receive any proceeds from the sale of shares by the Selling Stockholder. The Selling Stockholder's gross proceeds were approximately $2.7 billion.

  3. Why are three directors resigning, and how will this change the Board?

    Joachim Creus, Frank Engelen and Olivier Goudet, who are affiliated with JAB BevCo B.V., each intend to resign effective upon closing of the offering. The filing states that their decisions were not the result of any disagreement with the Company or the Board. As a result, the Board will be reduced from eleven to eight directors.

  4. Under what registration was the offering made, and what agreement governs it?

    The offering was made under a previously filed Form S-3 registration statement (File No. 333-266989) and a resale prospectus supplement filed August 19, 2022, as supplemented by a prospectus supplement filed February 28, 2025. The Underwriting Agreement, dated February 26, 2025, among the Company, the Selling Stockholder and J.P. Morgan Securities LLC, is filed as Exhibit 1.1.